The article below represents a preview only and is not meant for reuse or republishing.
Sartorius to acquire select Danaher Life Science platform biz
Click here to read full article from source
Singapore, Oct. 21 -- Sartorius Stedim Biotech (SSB) has agreed to acquire parts of Danaher's Life Science portfolio as part of a broader transaction between Danaher and Sartorius Group, SSB's major shareholder. The total purchase price is approximately $750 million in cash of which about a quarter will be allocated to the businesses purchased by SSB. The final purchase price allocation will be subject to the closing process.
The businesses to be acquired by SSB had combined sales turnover of approximately $70 million in 2018 and strong double-digit profit margins. They employ approximately 110 people worldwide. The proposed transaction is expected to be completed in the first quarter of 2020 and is subject to customary closing condition...
To read the full article or to get the complete feed from this publication, please Contact Us